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REMINDERS
Enter audio code when using both computer 
and phone for better audio quality for all.
Please note your name, then add your 
comment or question
FOR ZOOM CALLERS
Review sign-on instructions carefully to assure 
a good audio experience.
Please mute audio
FOR IN-PERSON ATTENDEES
Please speak towards the microphones
Use the Zoom Mute, Start/Stop Video, and 
Chat Box if needed
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LEARNING OBJECTIVES
After participating in this activity, learners will 
be able to:
Recognize the importance of addressing 
stigma to promote access to and quality of 
integrated care delivery for patients and 
families affected by behavioral health (BH) 
challenges, especially opioid use disorder 
(OUD).
Summarize current evidence about the 
etiology and effective treatment of OUD and 
how stigma can impact delivery of evidence-
based care.
Describe strategies to reduce stigma in 
BH/OUD care delivery such as changes in 
language and addressing misconceptions 
about BH/OUD causes and recovery. 
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I am mentally 
ill so I must be 
weak.
Harm
Because I am 
weak, I am not 
worthy or able
SO WHY TRY…
(Corrigan and Rao, 2012)
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Learning Objectives
1. Understand role of stigma in caring for people 
with SUD
2. Recognize neurobiology of addiction in treating 
SUD with chronic disease model
3. Identify role of stigmatizing language and 
compassion fatigue as potential barriers in caring 
for people with SUD
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Who’s Heard?…
▪He’s just another addict…
▪She doesn’t deserve another chance…
▪You’re just substituting one drug for another…
▪You’re just another drug dealer…
▪ Is he going to be on Suboxone forever?....
▪Medications aren’t recovery…
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Where You Stand Depends…
Moral Model of Drug Use
▪ Drugs are bad
▪ People choose to use drugs
▪ People who use drugs are bad
▪ Drug use is moral failure
▪ People who use drugs can 
choose to stop
▪ We can make people stop 
using drugs if we make their 
lives uncomfortable (e.g. jail)
▪ Medications to treat SUD are 
just trading one addiction for 
another
Behavioral/Med Model Drug Use
▪ People learn to use drugs to cope 
with suffering
▪ Early exposure & trauma are 
strongly related to dev of SUD
▪ SUD alters brain structures & 
chemistry & becomes med 
condition
▪ Physical dependence/cravings 
with some drugs (e.g. opioids) 
creates neg cycle of cont’d use
▪ Medications are effective in 
treating SUD; abstinence only is 
often ineffective
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Current State of Affairs: Do Clinicians…
▪Think SUD is different from other chronic conditions 
because using substances is a choice?
▪Think treatment with opioid agonist is replacing one 
drug w/ another?
▪Feel people who use drugs are committing crime & 
deserve punishment?
16
A Tri-State Collaborative Program Managed by Maine Quality Counts
Current State of Affairs?
▪31% felt SUD is different from other chronic 
conditions because using substances is a choice
▪14% thought treatment with opioid agonist is 
replacing one drug w/ another
▪12% said people who use drugs are committing crime 
& deserve punishment
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Wakeman S et al, Attitudes, practices & preparedness to care for SUD: 
Results from survey general internists, Sub Abuse, 2016
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Stigma
▪Strong feelings of disapproval or disgrace that 
sets a person apart from others
▪Associated with negative attitudes & beliefs
▪Can lead to negative actions, discrimination
▪Self-stigma also significant challenge in SUD
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▪ The “right” pathway to recovery…
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Neurobiology of Addiction
▪Stages of addiction:
– Use/ binge  intoxication, dopamine release 
(“reward system”)
– Withdrawal  negative effect
– Preoccupation / anticipation  pursuit
▪Addiction changes brain structures & neurochemistry, 
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Neurobiology of Addiction
▪ Addiction changes brain 
structures, brain chemistry
▪ Resets brain’s reward system
– Over time, drug consumption 
triggers less dopamine, more 







A Tri-State Collaborative Program Managed by Maine Quality Counts
SUD Treatment with Medications (MAT) Works, AND Still 
Greatly Underused
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▪Strong evidence for effectiveness of medications for 
OUD treatment - i.e. methadone, buprenorphine, 
naltrexone
–Save lives, decreases OD deaths
–Reduce harm from illicit drug use
–Reduce craving, allowing more focus on recovery
–Decrease risk of relapse, increases rates of recovery
•AND, strong evidence that MAT still widely under-
utilized – in Maine & nationally 
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FDA-Approved Medications for OUD
▪Methadone
– Opioid agonist, FDA-approved since 1971
– Can only be administered by federally-recognized “Opioid 
Treatment Program” (OTP/methadone clinic)
▪Buprenorphine
– Partial opioid agonist, FDA-approved in2002
– Can be administered in office-based treatment programs by 
prescribers with DEA X-waiver or OTP
– Can be prescribed X3 doses by any DEA licensed physician
▪Naltrexone
– Opioid antagonist/blocker, FDA-approved in 1984 (tabs), 2010 (IM)
– Can be administered by any prescribing clinician
– Available as IM, tablet (poor adherence, not widely used)
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Maintenance: 75% Abstinent at 1 year
0% mortality
HR = 58.7, p .0001
Kakko, Lancet 2003
No meds (“Detox”): 0% Abstinent at 1 year
20% mortality!
“Abstinence” vs. Buprenorphine
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Defining Addiction
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▪“A chronic, relapsing brain disease that is 
characterized by compulsive drug seeking and use, 
despite harmful consequences
▪Considered brain disease because drugs change the 
brain… structure and how it works… that can be long 
lasting and lead to many harmful, self-destructive 
behaviors”*
*NIH National Institute of Drug Abuse
Addiction is Chronic Disease
JAMA, 284:1689-1695, 2000
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Does Language Matter?
▪Randomized trial used case vignettes test impact of 
specific language on clinicians’ assessment of pts
▪Using “substance abuse” vs. “SUD” strongly 
correlated with negative clinician beliefs  - i.e.
–Individuals personally culpable for their disease
–Punitive measures should be taken
▪Many words can trigger negative associations – e.g.
– Relapse vs. recurrence of use
– Pharmacotherapy vs. Medication Assisted Therapy
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Kelly J, et al, “Does it matter how we refer to individuals with substance-related conditions  A 
randomized study of two commonly-used terms, Interntl Journ Drug Policy, 2010.
Ashford RD, et al, “Substance use, recovery, & linguistics: The impact of words on explicit and 
implicit bias”, Drug & Alcohol Dependence, 2018.
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Language Matters
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Language 
Matters
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QC Substance Use Conversation Guide
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▪Effort to address stigma by improving care conversations 
▪Promotes…
–Language that promotes self-esteem and self-efficacy
–Use of motivational Interviewing to engage patients with SUD
–Use of scripting to support better conversations
–Coordination of treatment providers
▪Suggested uses:
–Introduce in staff meetings
–Laminate tools and hang in break rooms
–Identify practice team to pilot scripts 
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Sample Scripts
32




▪Build in time for relationship
▪Use trauma-informed approaches
▪Celebrate the victories (recovery is energizing!)
▪Recognize the humanity in everyone
33
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https://www.sevendaysvt.com/vermont/madelyn-linsenmeir-1988-2018/Content?oid=21797604
Obituary: Madelyn Linsenmeir, 1988-2018
“Our beloved Madelyn Ellen Linsenmeir died on 
Sunday, October 7. While her death was 
unexpected, Madelyn suffered from drug 
addiction, and for years we feared her addiction 
would claim her life. We are grateful that when she 
died, she was safe and she was with her family…
…If you are reading this with judgment, educate 
yourself about this disease, because that is what it 
is. It is not a choice or a weakness. And chances are 
very good that someone you know is struggling 
with it, and that person needs and deserves your 
empathy and support.
If you work in one of the many institutions through 
which addicts often pass — rehabs, hospitals, jails, 
courts — and treat them with the compassion and 
respect they deserve, thank you. If instead you see 
a junkie or thief or liar in front of you rather than a 
human being in need of help, consider a new 
profession.”
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What if We Treated Diabetes Like Addiction?
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Would we…
• Imply (or say) that poor lifestyle choices have caused the disease?
• Say elevated blood glucose makes blood “dirty”?
• Plan to treat with insulin for only 2 years, then insist on changing 
lifestyle enough to taper off?  
• Or… decline to treat at all?
• Insist that patients must go to diabetes education classes to 
continue treating them?
• Discharge patients from treatment if they choose to eat poorly, 
don’t lose weight, and/or have a persistently high blood sugar?
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Busting the Myths
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▪ SUD/OUD is hopeless – there’s no point in treating it
– SUD/OUD is chronic condition that responds to tx
– Recovery is possible
▪ I/We don’t believe in MAT
– Evidence is strong for effectiveness of MAT
– This is science, not a religion
▪ Isn’t it just substituting one drug for another?
–Recognize huge difference between addiction and 
physical dependence
– SUD tx/MAT allows people to return to functional lives
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▪The illness is not the person
– Remember the humanity in everyone
– No one would choose a life of addiction
– This could be your son or daughter
▪Treatment works & recovery is possible
– Evidence for MAT effectiveness better than most 
other chronic conditions we treat
Changing Hearts & Minds
37
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Objectives
 Recognize multiple pathways into substance use and into recovery
 Describe harm reduction approaches to effectively support people 
who use drugs
Graphic credit: Harm Reduction Coalition, 





•12 Step Fellowships (Gamblers Anonymous, 

























Adapted Graphic credit: Kevin Irwin
A Continuum of Substance Use
Reframing the Starting Point:
Engagement in Care
Acceptance 
✦ Provider Humility 
✦ Curiosity to Learn About SUD
➔ Supportive and Pragmatic Conversation
Less About What 
You Say 
More About Your 
Approach
Every Interaction Can Be An Opportunity to 
Engage
 Client goals are most likely be achieved
 Untimely push for abstinence only goals is likely to result in lower engagement
 Goal: provide support and resources for client’s self defined goals 
 PWUD are interested and capable of making changes to improve health and 
safety
 Safety messages shared could be rapidly spread through a social network
 Recognize and support readiness to change, whether safer injecting or 
recovery
Drug The drug itself: what it does and how potent it is
What it is cut with
How it is used: smoke, snort, absorbed, swallowed, injected
Whether it is illegal or legal
Set Person’s unique physiology
Person’s physical health
Person’s mental or emotional state
Person’s cultural identity, culture of origin, sense of belonging
Expectation of the drug and motivation for using the drug
Setting Stressors in a person’s life: Social, Economic, Environmental
Support in PWUD’s life
With whom and where a person uses









Syringe Service Program Engagement
Evidence for Syringe Service Programs 
and Harm Reduction
Safer Supplies
 Ask: “Are you able to get clean supplies (needles, cookers, cottons)?”
 If needles have to be reused, HCV can be reduced and HIV eliminated 
with bleach.7
Risk dramatically reduced with rinsing 3 times with water
Advise using clean, single use works
Cottons, cookers, and clean water (sterile)
DISCERNNE Preliminary Results
Drug Injection Surveillance and Care Enhancement for 
Rural Northern New England
N = 421
• 52% Shared Injection Equipment
• 44% Obtaining Syringes from Dealer, Street Seller, or 
Friend (NH)
• 15% in VT
• 13% in MA
• 42% in NH reported easy access to clean syringes
• 80% in VT
• 92% in MA
Safer Use
 Ask: “What steps do you take to keep yourself safe when 
using?”
Advise to not use alone and only with trusted people who 
can provide care if needed 
Caution with all drug supplies and new sources
Avoiding taking all the drug at once and avoid rushing
Starting with a “test shot” may help prevent overdose as 
drug cannot be taken back once injected.6
Problem solve around a safer environment and/or 
opportunities to decrease frequency.
Microscope View of Needle After Use
https://imgur.com/Rh7RY
Safer Injecting Practices: Safer Use
Ask: “How do you prevent injury to your veins and infections?”
• Wash hands or use hand sanitizer/ alcohol 
• Tourniquet improves vein access (fewer needle sticks, less 
risk for infection)
• Bevel up to avoid going through the vein
• Recognize valves in veins and inject above
• Recognize infections and when to seek care for wound/ 
illness/ infection
Safer Injecting Practices: Safer Disposal
Bring them back to SSP!
Some health, fire 
departments, and transfer 
stations provide safe places 
to dispose of syringes
If sharps container 
unavailable use hard plastic 
detergent bottles, seal, and 
mark “DO NOT RECYCLE”
Overdose Prevention
• 68,000 OD deaths 2017 (U.S.)
• 2017 OD Deaths: 488 in NH and 418 in ME
Overdose Prevention
Fentanyl Test Strips
Much of the opioid supply in the 
area has fentanyl
Great for those want to check 
their heroin supply or other drugs
Approx 68% with a positive test 
took measures to reduce risk and 
23% who were negative also took 
measures to reduce risk
Health Promotion
 Offer Preventative Care: Screening, Testing, and Education 
 HIV testing is recommended at least annually for PWID
Include HIV 1/2 antibody and HIV 1 p24 antigen testing (positive 21 days after 
infection).9
Consider discussing PreExposure Prophylaxis (PrEP) for HIV prevention.
 (CDC, 2017)
 Hepatitis C antibody testing is recommended periodically for PWID.10
Check immunization status 
 Discuss safe sexual practices 
 Review pregnancy prevention options







”I know best for person/group”





Narrow the scope of care
Provide substandard care














”I know best” for person or group 
(But I’ll ‘give’ opportunity to 
participate in my decision)
RECEPTION
ACTION
‘Sell’ on particular ‘product’/idea





“You know better than me. Let me 
help you decide/improve/get you 
where you want to be.”






















Harm Reduction Education and Technical 
Assistant Project
Provide education and support to NH providers on integrating harm reduction in practice
• Academic detailing 1-on-1 visits with providers who connect with people who use drugs
• 150-200 providers in healthcare, community service agencies
• Provide technical assistance on integrating harm reduction
• 1 hour trainings at practice sites led by NHHRC
• Resource provision and research
• Biweekly case conferencing sessions
• Beginning June 2019
• Recruiting for:
• Advisory group members
• Academic detailers
• Practice site participants
• For more info email HRETA.Project@unh.edu
Interested in Learning More? 
Getting Involved?
info@nhhrc.orgwww.nhhrc.org
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